CADTH Program Updates Pending Consultation on Aligned CADTH Review Procedures In Spring 2020, CADTH will be consulting stakeholders on its aligned procedures for its drug reimbursement reviews. The...

CADTH Program Updates 1. COVID-19 Update CADTH continues to support health care decision-makers throughout this challenging period. We have established a new website with information related to COVID...

See Pharmaceutical Reviews Update ― Issue 31 for important news and information regarding CADTH’s drug review programs. Highlights from this issue include: changes to filing new information during the...

CADTH Program Updates 1. New CADTH Process for Cell and Gene Therapies CADTH has undertaken an internal review of our processes for drugs and devices, and established a revised process for the review...

CADTH Program Updates 1. CADTH Drug Portfolio Information Session This annual session is an opportunity for all interested stakeholders to get the latest information about priority initiatives and...

Updates for Patients and Communities​ We’ve surprised a few patient groups recently with our belated thank you letters. Our letters highlight in detail how the group’s input was used in our review...

Updates for Patients and Communities CADTH understands that patients and patient groups may have new or heightened responsibilities (both personally and professionally) as a result of the COVID-19...

Update for Patients and Communities In introducing its aligned drug review process, CADTH also announced a new opportunity for patient participation by giving groups a chance to comment on draft...

CADTH Pharmaceutical Reviews Update — Issue 24 See Pharmaceutical Reviews Update – Issue 24 for important news and information regarding CADTH’s drug review programs. Highlights from this issue...

Update for Patients and Communities Before launching the Procedures for CADTH Reimbursement Reviews, CADTH held a six-week public consultation period during which we received and considered feedback...